COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Reduction of the share capital
24/04/2019
Bagsværd, Denmark, 24 April 2019 - At Novo Nordisk's Annual General Meeting on 21 March 2019, it was decided to reduce the company's B share capital from DKK 382,512,800 to DKK 372,512,800 by cancellation of part of the [...]
GYANT selected to the inaugural Mayo Clinic and Arizona State University MedTech Accelerator
24/04/2019
Collaboration with leading medical and research experts will validate company’s product offering for health systems, providers, and patients SAN FRANCISCO, April 24, 2019 (GLOBE NEWSWIRE) -- GYANT, a San Francisco-based [...]
Nicox: Number of voting rights as of 24 April 2019
24/04/2019
Nicox SA Société anonyme with a registered capital of € 29,909,120 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On April 24, 2019, MONTHLY PUBLICATION OF THE [...]
Nicox : Droits de vote 24 avril 2019
24/04/2019
Nicox SA Société anonyme au capital de 29 909 120 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 24 avril 2019, PUBLICATION MENSUELLE DU NOMBRE D’ [...]
EssilorLuxottica: The EssilorLuxottica’s Board of Directors voted against the proposed complementary resolutions submitted by shareholders for inclusion on the agenda of the May 16, 2019 General Meeting
24/04/2019
The EssilorLuxottica’s Board of Directors voted against the proposed complementary resolutions submitted by shareholders for inclusion on the agenda of the May 16, 2019 General Meeting Charenton-le-Pont, France (April [...]
EssilorLuxottica : Le Conseil d’administration d’EssilorLuxottica a voté contre les projets de résolutions complémentaires soumis par les actionnaires pour inscription à l’ordre du jour de l’Assemblée Générale du 16 mai 2019
24/04/2019
Le Conseil d’administration d’EssilorLuxottica a voté contre les projets de résolutions complémentaires soumis par les actionnaires pour inscription à l’ordre du jour de l’Assemblée Générale du 16 mai 2019 Charenton-le- [...]
Exercise of Restricted Stock Units
24/04/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Exercise of Restricted Stock Units and Total Voting Rights Oxford, UK, and Cambridge, MA, US, 24 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2019
24/04/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
Tabula Rasa HealthCare to Announce First Quarter 2019 Operating Results and Host Conference Call on Wednesday, May 8, 2019
24/04/2019
MOORESTOWN, N.J., April 24, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its first quarter 2019 operating [...]
Covetrus Announces First Quarter 2019 Earnings Release Date and Conference Call Information
24/04/2019
PORTLAND, Maine, April 24, 2019 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2019 results after the market [...]
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
24/04/2019
Lupus Patients with Elevated PC4d Levels Have Significantly Increased Occurrence of Thrombosis San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and [...]
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary Shares
24/04/2019
LONDON, April 24, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, today announces that, in connection with [...]
Relievant Announces Publication of SMART Trial 24-Month Results
24/04/2019
Intracept® Procedure Demonstrates Durable Results at 24 Months MINNEAPOLIS, April 24, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for [...]
Precipio Launches Global Expansion Strategy
24/04/2019
Precipio to capitalize on powerful data and expertise to grow business globally NEW HAVEN, Conn., April 24, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) announces the launch of [...]
Removing Obstacles from the Modern Infertility Patient’s Journey
24/04/2019
Results Show Patient Dropout is Low in an Employer-Sponsored High-Touch Program NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- RMA of New York, a Manhattan-based fertility clinic and Progyny, the leading fertility [...]
La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria
24/04/2019
-Designation offers potential for expedited development and review, and highlights the urgent need for additional treatment options for patients suffering from severe malaria- - NDA Planned for LJPC-0118 for Fourth [...]
NewLink Genetics to Host Its First Quarter 2019 Conference Call on May 8, 2019
24/04/2019
AMES, Iowa, April 24, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced it will host its first quarter 2019 conference call and webcast at 4:30 PM ET on Wednesday, May 8, 2019, to [...]
Orchestra BioMed™ Receives FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon (SEB)
24/04/2019
First and only non-coated sirolimus-eluting angioplasty balloon system to show promising clinical results Potential to offer significant advantages for treatment of coronary in-stent restenosis (ISR), a condition that [...]
Results from Clinical Trial Show Progenics’ PyL (18F-DCFPyL) PSMA PET/CT Imaging Agent Changes Management Plans for More Than 87% of Patients
24/04/2019
Data from a Prospectively Designed Independent Trial of 130 Patients showed that PyL upstaged and downstaged disease in 65.5% of patients NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. ( [...]

Pages